Skip to main content
logo
Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.92
+0.39 (7.05%)
Oct 19, 2026, 4:00 PM EDT - Market closed

Solid Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----8.0913.62
Revenue Growth
-----40.57%-
Gross Profit
-----70.33-45.12
Operating Income
-212.15-179.21-129.73-104.32-94.4-72.25
Net Income
-207.1-174.33-124.7-96.02-85.98-72.19
Earnings Per Share
-1.87-1.99-3.06-4.83-10.10-10.14
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
377.68187.85148.92123.64213.72207.78
Total Debt
20.1621.1624.1826.2728.552.06
Net Cash (Debt)
357.52166.69124.7497.38185.18205.72
Net Cash Growth
45.89%33.63%28.11%-47.41%-9.98%37.52%
Net Cash Per Share
3.231.903.064.9021.7528.90

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-186.84-156.29-100.01-94.18-97.98-77.76
Capital Expenditures
-0.97-1.15-0.65-1.52-3.02-1.28
Free Cash Flow
-187.81-157.44-100.67-95.7-100.99-79.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-----1166.35%-530.50%
Pretax Margin
-----1062.28%-530.01%
Profit Margin
-----1062.28%-530.01%
FCF Margin
-----1247.74%-580.36%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----12.9814.17